Cargando…
Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
The success of immunotherapy relies on the participation of all arms of the immune system and the role of CD4+ T lymphocytes in preventing tumor growth is now well established. Understanding how tumors evade immune responses holds the key to the development of cancer immunotherapies. In this review,...
Autores principales: | Thibodeau, Jacques, Bourgeois-Daigneault, Marie-Claude, Lapointe, Réjean |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3489746/ https://www.ncbi.nlm.nih.gov/pubmed/23162758 http://dx.doi.org/10.4161/onci.21205 |
Ejemplares similares
-
MHC class I antigen cross-presentation mediated by PapMV nanoparticles in human antigen-presenting cells is dependent on autophagy
por: Possamaï, David, et al.
Publicado: (2021) -
MHC Class II Auto-Antigen Presentation is Unconventional
por: Sadegh-Nasseri, Scheherazade, et al.
Publicado: (2015) -
Proteolysis and antigen presentation by MHC class II molecules
por: Bryant, Paula Wolf, et al.
Publicado: (2002) -
Causal ALS genes impact the MHC class II antigen presentation pathway
por: Chi, Binkai, et al.
Publicado: (2023) -
Antigen Processing for MHC Class II Presentation via Autophagy
por: Münz, Christian
Publicado: (2012)